[Federal Register Volume 72, Number 118 (Wednesday, June 20, 2007)]
[Notices]
[Page 34040]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-11915]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Application

    Pursuant to Title 21 Code of Federal Regulations 1301.34(a), this 
is notice that on April 23, 2007, Cambrex Charles City, Inc., 1205 11th 
Street, Charles City, Iowa 50616-3466, made application by letter to 
the Drug Enforcement Administration (DEA) for registration as an 
importer of the basic classes of controlled substances listed in 
schedules II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Thebaine (9333)............................  II
Raw Opium (9600)...........................  II
Concentrate of Poppy Straw (9670)..........  II
------------------------------------------------------------------------

    The company plans to import the listed controlled substances for 
manufacture of active pharmaceutical ingredients for sale to its 
customers.
    No comments, objections, or requests for any hearings will be 
received on any application for registration or re-registration to 
import crude opium, poppy straw, concentrate of poppy straw, and coca 
leaves.
    Any bulk manufacturer who is presently, or is applying to be, 
registered with DEA to manufacture such basic classes of controlled 
substances listed in schedule I or II, which fall under the authority 
of section 1002(a)(2)(B) of the Act (21 U.S.C. 952(a)(2)(B)) may file 
comments or objections to the issuance of the proposed registration and 
may, at the same time, file a written request for a hearing on such 
application pursuant to 21 CFR 1301.43 and in such form as prescribed 
by 21 CFR 1316.47.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Drug Enforcement Administration, Office of Diversion Control, 
Federal Register Representative (ODL), Washington, DC 20537; or any 
being sent via express mail should be sent to Drug Enforcement 
Administration, Office of Diversion Control, Federal Register 
Representative (ODL), 2401 Jefferson-Davis Highway, Alexandria, 
Virginia 22301; and must be filed no later than July 20, 2007.
    This procedure is to be conducted simultaneously with and 
independent of the procedures described in 21 CFR Sec.  1301.34(b), 
(c), (d), (e) and (f). As noted in a previous notice published in the 
Federal Register on September 23, 1975, (40 FR 43745), all applicants 
for registration to import a basic class of any controlled substances 
in schedule I or II are and will continue to be required to demonstrate 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, that the requirements for such 
registration pursuant to 21 U.S.C. 958(a), 21 U.S.C. 823(a), and 21 CFR 
1301.34(b), (c), (d), (e) and (f) are satisfied.

    Dated: June 7, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E7-11915 Filed 6-19-07; 8:45 am]
BILLING CODE 4410-09-P